Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The DEtermining Statin Intolerance FOr Rosuvastatin (DESIFOR) Trial

NCT03889314 is registered in ClinicalTrials.gov with Minneapolis Heart Institute Foundation as lead sponsor.

NCT NCT03889314
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03889314 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The DEtermining Statin Intolerance FOr Rosuvastatin (DESIFOR) Trial
Lead sponsor
Minneapolis Heart Institute Foundation
Phase
Phase 4
Overall status
Unknown status
Start date
April 26, 2019
Completion date
December 31, 2022
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adverse effect, cardiovascular diseases, cardiovascular risk factor